The global market for MRI-compatible IV infusion pump systems is poised for remarkable growth, projected to reach a staggering worth of US$ 580.3 million by 2032, according to recent market analysis. From its anticipated value of US$ 234.8 million by the end of 2022, this industry is expected to soar at a Compound Annual Growth …
Category Archives: Healthcare Trends
Global Oral Solid Dosage Pharmaceutical Formulation Industry Set to Surge with a Robust 6.4% CAGR by 2032, according to FMI
The global oral solid dosage pharmaceutical formulation industry is poised for remarkable growth, with a projected Compound Annual Growth Rate (CAGR) of 6.4% from 2022 to 2032. According to the latest industry assessments, the estimated market value is expected to reach US$ 1.0 billion by 2032, compared to US$ 555.3 million in 2022. A recent …
Global Medical Bionic Implant and Exoskeleton Market Projected to Reach US$ 1,361.90 Million by 2033 | FMI
The global medical bionic implant and exoskeleton market is poised for substantial growth, with estimates indicating a valuation of US$ 742.0 million by 2023, reflecting a significant increase from the recorded US$ 690.2 million in 2022. The market is projected to witness a robust 6.3% Compound Annual Growth Rate (CAGR) from 2023 to 2033, reaching …
Global Pancreatic Cancer Industry Ready to Hit US$ 7,541.09 Million by 2033 with a Noteworthy CAGR of 13.5% | FMI
In a groundbreaking revelation, Future Market Insights Inc. A renowned healthcare analysis firm has released a comprehensive analysis of the Global Pancreatic Cancer Industry, projecting a valuation of approximately US$ 2,125.57 Million by the end of 2023. The study anticipates an extraordinary Compound Annual Growth Rate (CAGR) of 13.5%, laying the foundation for a significant …
Global Non-Small Cell Lung Carcinoma (NSCLC) Industry Aims for US$ 21.40 Billion Valuation by 2033, Fueled by a Solid 10% CAGR | FMI
In a groundbreaking revelation, the Global Non-Small Cell Lung Carcinoma (NSCLC) Industry is on the brink of an extraordinary transformation, with market projections set to reach an impressive US$ 8.25 billion in 2023 and an astounding US$ 21.40 billion by 2033, exhibiting a robust Compound Annual Growth Rate (CAGR) of 10%. This seismic shift is …
Global Intratumoral Cancer Therapies Industry Projected to Hit US$ 552.36 Billion with a Striking 10% CAGR by 2033 | FMI
The Global Intratumoral Cancer Therapies Industry is set to undergo a substantial transformation, projecting a market value of US$ 552.36 Billion by the year 2033, according to a newly released study by Future Market Insights (FMI). The report indicates a significant leap from the market value of US$ 212.96 Billion in 2023, reflecting an impressive …
Global Vessel Sealing Devices Industry, Targeting US$3.9 Billion by 2033 with a Commanding 9% CAGR and Influential Growth Factors | Reveals by FMI
The Global Vessel Sealing Devices Industry is gearing up for a transformative surge, according to industry estimates, positioning itself for an impressive trajectory from US$ 1.65 billion in 2023 to an astounding US$ 3.9 billion by 2033. Anchoring this exponential growth is a projected Compound Annual Growth Rate (CAGR) of 9%, heralding a new era …
Global Catheter-Related Bloodstream Infection (CRBSI) Treatment Industry Set to Surge with a 5.6% CAGR, anticipated to Hit US$ 2,668.6 Million by 2033 | FMI
The Global Catheter-Related Bloodstream Infection (CRBSI) Treatment Industry has demonstrated remarkable strength, with a valuation of US$ 1,466.9 million in 2022. According to the latest insights from Future Market Insights Inc., the market is projected to reach an impressive US$ 2,668.6 million by 2033, showcasing a substantial growth trajectory. In a recent report, it was …
Global Swine Vaccine Industry Eyes a Consistent 6.1% CAGR, Envisioning a Milestone US$ 112 Million Valuation by 2032 | Reports FMI Insights
The Global Swine Vaccine Industry is poised to reach a significant milestone, with Future Market Insights (FMI) projecting a robust valuation of US$ 112 million by the year 2032. FMI’s latest report highlights a steady Compound Annual Growth Rate (CAGR) of 6.1% between 2022 and 2032, translating to a substantial absolute dollar opportunity of US$ …
Global Automated and Closed Cell Therapy Systems Industry Poised for Meteoric 22.8% CAGR Growth, anticipated to Hit US$9.4 Billion by 2033 | FMI
In a visionary stride toward the future of bioprocessing, the Global Automated and Closed Cell Therapy Processing Systems Industry is poised for an extraordinary surge, with a projected 22.8% Compound Annual Growth Rate (CAGR). From its current standing as a US$1.2 billion industry in 2023, the market is set to undergo a transformative journey, reaching …